-
Andino R. RNAi puts a lid on virus replication[J]. Nat Biotechnol, 2003, 21(): 629-630. doi: 10.1038/nbt0603-629
-
Bhuyan P K, Kariko K, Capodici J. Short interfering RNA-mediated inhibition of herpes simplex virus type 1 gene expression and function during infection of human keratinocytes[J]. J Virol, 2004, 78(): 10276-10281. doi: 10.1128/JVI.78.19.10276-10281.2004
-
Brandt C R, Kintner R L, Pumfrey A M. The herpes simplex virus ribonucleotide reductase is required for ocular virulence[J]. J Gen Virol, 1991, 72(): 2043-2049. doi: 10.1099/0022-1317-72-9-2043
-
Cameron J M, Mcdougall I, Marsden H S. Ribonucleotide reductase encoded by herpes simplex virus is a determinant of the pathogenicity of the virus in mice and a valid antiviral target[J]. J Gen Virol, 1988, 69(): 2607-2612. doi: 10.1099/0022-1317-69-10-2607
-
Cory J G. Ribonucleotide reductase as a chemotherapeutic target[J]. Adv Enzyme Regul, 1988, 27(): 437-455. doi: 10.1016/0065-2571(88)90030-1
-
David J G, Sandra K W. Herpes Simplex Virus Type 1-Induced Ribonucleotide Reductase Activity Is Dispensable for Virus Growth and DNA Synthesis: Isolation and Characterization of an ICP6 lacZ Insertion Mutant[J]. J Virol, 1988, 62(): 196-205.
-
Elbashir S M, Harborth J, Weber K. Analysis of gene function in somatic mammalian cells using small interfering RNAs[J]. Methods, 2002, 26(): 199-213. doi: 10.1016/S1046-2023(02)00023-3
-
Frame M C, Marsden H S, Dutia B M. The ribonucleotide reductase induced by herpes simplex virus type 1 involves minimally a complex of two polypeptides (136K and 38K)[J]. J Gen Virol, 1985, 66(): 1581-1587. doi: 10.1099/0022-1317-66-7-1581
-
Honess R.W, Roizman B. Proteins specified by herpes simplex virus. XI. Identification and relative molar rates of synthesis of structural and non-structural herpes virus polypeptides in infected cells[J]. J Virol, 1973, 12(): 1347-1365.
-
Honess R W, Roizman B. Regulation of herpes virus macromolecular synthesis.Ⅰ. Cascade regulation of the synthesis of three groups of viral proteins[J]. J Virol, 1974, 14(): 8-19.
-
Holen T, Amarzguioui M, Wiiger M T. Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor[J]. Nucleic Acids Res, 2002, 30(): 1757-1766. doi: 10.1093/nar/30.8.1757
-
Idowu A D, Fraser-Smith E B, Poffenberger K L. Deletion of the herpes simplex virus type 1 ribonucleotide reductase gene alters virulence and latency in vivo[J]. Antiviral Res, 1992, 17(): 145-156.
-
Ingemarson R, Lankinen H. The herpes simplex virus type 1 ribonucleotide reductase is a tight complex of the type alpha 2 beta 2 composed of 40K and 140K proteins, of which the latter shows multiple forms due to proteolysis[J]. Virology, 1987, 156(): 417-422. doi: 10.1016/0042-6822(87)90422-3
-
Jacobson J G, Leib A D, Goldstein D J. A herpes simplex virus ribonucleotide reductase deletion mutant is defective for productive acute and reactivatable latent infections of mice and for replication in mouse cells[J]. Virology, 1989, 173(): 276-283. doi: 10.1016/0042-6822(89)90244-4
-
Jiang M, Milner J. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference[J]. Oncogene, 2002, 21(): 6041-6048. doi: 10.1038/sj.onc.1205878
-
Kawasaki H, Suyama E, Iyo M. siRNAs generated by recombinant human Dicer induce specific and significant but target site-independent gene silencing in human cells[J]. Nucl Acids Res, 2003, 31(): 981-987. doi: 10.1093/nar/gkg184
-
Khvorova A, Reynolds A, Jayasena S D. Functional siRNAs and rniRNAs exhibit strand bias[J]. Cell, 2003, 115(): 209-216. doi: 10.1016/S0092-8674(03)00801-8
-
Livak K J, Schmittgen T D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔCT)[J]. Methods, 2001, 25(): 402-408. doi: 10.1006/meth.2001.1262
-
Luo K Q, Chang D C. The gene-silencing efficiency of siRNA is strongly dependent on the local structure of mRNA at the targeted region[J]. Biochem Biophys Res Commun, 2004, 318(): 303-310. doi: 10.1016/j.bbrc.2004.04.027
-
Mcgeoch D J, Dalrymple M A, Davison A J. The complete DNA sequences of the long unique region in the genome of herpes simplex virus type 1[J]. J Gen Virol, 1988, 69(): 1531-1574. doi: 10.1099/0022-1317-69-7-1531
-
Preston V G, Coates J A, Rixon F J. Identification and characterization of a herpes simplex virus gene product required for encapsidation of virus DNA[J]. J Virol, 1983, 45(): 1056-1064.
-
Preston V G, Palfreyman J W, Dutia B M. Identification of a herpes simplex virus type 1 polypeptide which is a component of the virus-induced ribonucleotide reductase[J]. J Gen Virol, 1984, 65(): 1457-1466. doi: 10.1099/0022-1317-65-9-1457
-
Pu Y, Liu L D, Ma S H. Analysis of siRNA interfering in the alpha 22 immediate early gene of HSV-1[J]. Virol Sin, 2005, 20(): 221-224.
-
Ren Z, Zhang M Y, Kitazato K. Effect of siRNA on HSV-1 plaque formation and relative expression levels of UL39 mRNA[J]. Arch Virol, 2008, 153(): 1401-1406. doi: 10.1007/s00705-008-0110-1
-
Ren Z, Zhang C H, Wang L J. In Vitro Anti-viral Activity of the Total Alkaloids from Tripterygium Hypoglaucum against Herpes Simplex Virus Type 1[J]. Virol Sin, 2010, 25(): 107-114. doi: 10.1007/s12250-010-3092-6
-
Robins M J. Mechanism-based inhibition of ribonucleotide reductases: new mechanistic considerations and promising biological applications[J]. Nucleosides Nucleotides, 1999, 18(): 779-793. doi: 10.1080/15257779908041565
-
Schubert S, Grunweller A, Erdmann V A. Local RNA target structure influences siRNA efficacy: systematic analysis of intentionally designed binding regions[J]. J Mol Bio, 2005, 348(): 883-893. doi: 10.1016/j.jmb.2005.03.011
-
Song E, Lee S K, Wang J. RNA interference targeting Fas protects mice from fulminant hepatitis[J]. Nat Med, 2003, 9(): 347-351. doi: 10.1038/nm828
-
Szekeres T, Fritzer-Szekeres M, Elford H L. The enzyme ribonucleotide reductase: target for antitumor and anti-HIV therapy[J]. Crit Rev Clin Lab Sci, 1997, 34(): 503-528. doi: 10.3109/10408369709006424
-
Thelander L, Reichard P. Reduction of ribonucleotides[J]. Annu Rev Biochem, 1979, 48(): 133-158. doi: 10.1146/annurev.bi.48.070179.001025
-
Vickers T A, Koo S, Bennett C F. Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysis[J]. J Biol Chem, 2003, 278(): 7108-7118. doi: 10.1074/jbc.M210326200
-
Yamada Y, Kimura H, Morishima T. The pathogenicity of ribonucleotide reductase-null mutants of herpes simplex virus type 1 in mice[J]. J Infect Dis, 1991, 164(): 1091-1097. doi: 10.1093/infdis/164.6.1091
-
Zhu Q C, Ren Z, Zhang C L. Silencing HSV-1 gD expression in cultured cells by RNA interference[J]. Chin J Virol, 2007, 23(): 22-27.